Compounds > cp-55,940
Page last updated: 2024-08-26

cp-55,940 and am 630

cp-55,940 has been researched along with am 630 in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's1 (11.11)29.6817
2010's7 (77.78)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brockie, HC; Makriyannis, A; Murphy, VL; Pertwee, RG; Ross, RA; Stevenson, LA; Templeton, F1
Astruc-Diaz, F; Cavasotto, CN; Diaz, P; Naguib, M; Phatak, SS; Xu, J1
Allen, JG; Babij, P; Fotsch, C1
Brogi, S; Corelli, F; Di Marzo, V; Ligresti, A; Mugnaini, C; Pasquini, S; Tafi, A1
Altmann, KH; Anavi-Goffer, S; Gertsch, J; Huefner, A; Kleyer, J; Paredes, JM; Raduner, S; Schuehly, W1
Chen, X; Darras, FH; Decker, M; Heilmann, J; Nimczick, M; Pemp, D1
Cooper, AG; Glass, M; Hook, S; MacDonald, C; Tyndall, JDA; Vernall, AJ1
Abate, M; Arena, C; Bertini, S; Bifulco, M; Chicca, A; Ciaglia, E; Digiacomo, M; Gado, F; Gertsch, J; Lapillo, M; Macchia, M; Manera, C; Poli, G; Tuccinardi, T1
Cheng, J; McCorvy, JD; Tan, L; Yan, W1

Reviews

2 review(s) available for cp-55,940 and am 630

ArticleYear
Emerging targets in osteoporosis disease modification.
    Journal of medicinal chemistry, 2010, Jun-10, Volume: 53, Issue:11

    Topics: Animals; Biomarkers; Bone Density; Bone Resorption; Humans; Osteoporosis

2010
Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure-Functional Selectivity Relationships (SFSRs) and Therapeutic Potential.
    Journal of medicinal chemistry, 2018, 11-21, Volume: 61, Issue:22

    Topics: Animals; Drug Discovery; Humans; Ligands; Receptors, G-Protein-Coupled; Signal Transduction; Structure-Activity Relationship

2018

Other Studies

7 other study(ies) available for cp-55,940 and am 630

ArticleYear
Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630.
    British journal of pharmacology, 1999, Volume: 126, Issue:3

    Topics: Animals; Benzoxazines; Binding, Competitive; Camphanes; Cannabinoids; CHO Cells; Chromans; Colforsin; Cricetinae; Cyclic AMP; Cyclohexanols; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Indoles; Morpholines; Naphthalenes; Pyrazoles; Radioligand Assay; Receptors, Cannabinoid; Receptors, Drug; Tritium

1999
6-Methoxy-N-alkyl isatin acylhydrazone derivatives as a novel series of potent selective cannabinoid receptor 2 inverse agonists: design, synthesis, and binding mode prediction.
    Journal of medicinal chemistry, 2009, Jan-22, Volume: 52, Issue:2

    Topics: Crystallography, X-Ray; Hydrazones; Hydrogen Bonding; Isatin; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Structure; Protein Binding; Receptor, Cannabinoid, CB2

2009
Three-dimensional quantitative structure-selectivity relationships analysis guided rational design of a highly selective ligand for the cannabinoid receptor 2.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:2

    Topics: Computer Simulation; Drug Design; Humans; Ligands; Models, Molecular; Molecular Structure; Quantitative Structure-Activity Relationship; Quinolones; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Recombinant Proteins; Stereoisomerism

2011
Mechanisms of osteoclastogenesis inhibition by a novel class of biphenyl-type cannabinoid CB(2) receptor inverse agonists.
    Chemistry & biology, 2011, Aug-26, Volume: 18, Issue:8

    Topics: Animals; Biphenyl Compounds; Calcium; Cannabinoid Receptor Modulators; Cell Line; Cell Migration Inhibition; Cells, Cultured; Cyclic AMP; Humans; Lignans; Macrophages; Mice; Monocytes; Osteoclasts; Osteogenesis; Plant Extracts; Plants; Receptor, Cannabinoid, CB2; Tumor Necrosis Factor-alpha

2011
Synthesis and biological evaluation of bivalent cannabinoid receptor ligands based on hCB₂R selective benzimidazoles reveal unexpected intrinsic properties.
    Bioorganic & medicinal chemistry, 2014, Aug-01, Volume: 22, Issue:15

    Topics: Benzimidazoles; Drug Design; Humans; Kinetics; Ligands; Protein Binding; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2

2014
Alkyl indole-based cannabinoid type 2 receptor tools: Exploration of linker and fluorophore attachment.
    European journal of medicinal chemistry, 2018, Feb-10, Volume: 145

    Topics: Dose-Response Relationship, Drug; Fluorescent Dyes; Humans; Indoles; Ligands; Models, Molecular; Molecular Structure; Receptor, Cannabinoid, CB2; Structure-Activity Relationship

2018
Polypharmacological profile of 1,2-dihydro-2-oxo-pyridine-3-carboxamides in the endocannabinoid system.
    European journal of medicinal chemistry, 2018, Jun-25, Volume: 154

    Topics: Dose-Response Relationship, Drug; Endocannabinoids; Humans; Molecular Docking Simulation; Molecular Structure; Pyridines; Receptors, Cannabinoid; Structure-Activity Relationship; Tumor Cells, Cultured; U937 Cells

2018